Articles On Polynovo (ASX:PNV)

World Overnight SPI Overnight (Dec) 5942.00 – 103.00 – 1.70% S&P ASX 200 6057.70 + 6.70 0.11% S&P500 3271.03 – 119.65 – 3.53% Nasdaq Comp 11004.87 – 426.48 – 3.73% DJIA 26519.95 – 943.24 – 3.43% S&P500 VIX 40.28 +...

ShareCafeOvernight: Rolling Lockdowns World Overnight SPI Overnight (Dec) 5942.00 – 103.00 – 1.70% S&P ASX 200 6057.70 + 6.70 0.11% S&P500 3271.03 – 119.65 – 3.53% Nasdaq Comp 11004.87 – 426.48 – 3.73% DJIA 26519.95 – 94...

Summary Medical device player PolyNovo Limited has received a green light from Taiwan FDA for the sale of NovoSorb BTM in Taiwan. The Company has also signed a contract with Taiwan-based Evermed to sell its NovoSorb BTM. PolyNovo discl...

28 Oct 2020 - PolyNovo (ASX:PNV) has announced the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan.

With populations around the world getting older and chronic disease burden increasing, demand for healthcare services is expected to rise strongly over the coming decades. In light of this, I think the healthcare sector could be a great pl...

On Thursday eligible shareholders of Wesfarmers Ltd (ASX: WES) will be paid the conglomerate’s final dividend. The Bunnings owner is rewarding shareholders with a fully franked 95 cents per share final dividend, which was up almost 22% yea...

PolyNovo Ltd (ASX: PNV) is an exciting name in the health-tech space. As you can see in the chart below, it’s been a volatile ride so far. Here are my thoughts on this up and coming ASX growth share. Source: Rask Media PNV 1-year share pric...

The S&P/ASX 200 Index (ASX: XJO) is back in form at last on Wednesday and is charging notably higher. The benchmark index is currently up 1.8% to 5,888.6 points. Four shares that have climbed more than most today are listed below. Here...

23 Sep 2020 - PolyNovo (ASX:PNV) is excited to announce the appointment of Innova Medical Oy, in Helsinki, to sell NovoSorb® BTM in Finland.

In morning trade on Wednesday the PolyNovo Ltd (ASX: PNV) share price is pushing higher with the market. At the time of writing the medical device company’s shares are up 1.5% to $2.22. This latest gain means the PolyNovo share price is up...

If you have $3,000 to invest in ASX growth shares, then I think the ones listed below would be top options after recent market weakness. Here’s why I would invest $1,000 across each of these growth shares: Kogan.com Ltd (ASX: KGN) The firs...

I continue to believe that the healthcare sector is a great place to invest with a long term view. This is due to favourable industry tailwinds which look set to support demand for healthcare services for a long time to come. While I think...

ASX tech shares have been rocketing in 2020 thanks to the likes of Afterpay Ltd (ASX: APT). The Afterpay share price has surged 144.9% higher but I think the tide is starting to turn. In my mind, biotech shares like Polynovo Ltd (ASX: PNV)...

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price had a good day on Thursday. Shares in the Aussie pharma group rocketed 9.2% higher to lead the S&P/ASX 200 Index (ASX: XJO) winners. So, what’s causing a surge in Aussie pharm...

I believe that one of the best ways for investors to grow their wealth is to make long term investments in quality shares with strong business models and positive outlooks. Two ASX growth shares that tick a lot of boxes for me right now ar...

It’s been a strong year for many ASX growth shares. Healthcare, gold and tech shares have performed strongly despite the S&P/ASX 200 Index (ASX: XJO) slumping lower. However, it’s hard to know what to buy in the current market. Looking...

The Polynovo Ltd (ASX: PNV) share price has dropped lower in early afternoon trade despite the company announcing it has received a grant from the Victorian Government for its hernia facility. At the time of writing, the Polynovo share pri...

The Mesoblast Limited (ASX: MSB) share price outperformed in August. Shares in the Aussie biotech are up 37.9% in the space of a month after a busy August earnings season.  Why is the Mesoblast share price rocketing higher? August was full...

The A2 Milk Company Ltd (ASX: A2M) share price may be under pressure today following heavy insider selling, but not all executives have been selling shares this week. The Polynovo Ltd (ASX: PNV) share price is storming higher on Friday aft...

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a disappointing decline. At the time of writing the benchmark index is down a sizeable 0.9% to 6,072.2 points. Four shares that have not let that hold them back are lis...

World Overnight SPI Overnight (Sep) 6076.00 – 9.00 – 0.15% S&P ASX 200 6126.20 + 9.80 0.16% S&P500 3484.55 + 5.82 0.17% Nasdaq Comp 11625.34 – 39.72 – 0.34% DJIA 28492.27 + 160.35 0.57% S&P500 VIX 24.47 + 1.20 5.16...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accent Group ((ACF)) - Acrow Formwork And Construction ((ABC)) - AdBri ((AMA)) - Ama Group ((APA)) - APA Group ((AMI)) - Aurelia Metals ((BVS)) - Bravura Solutio...

ShareCafeOvernight: Fly Me To The Moon World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48...

World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48 0.30% S&P500 VIX 23.27 + 1.24 5.6...

The Polynovo Ltd (ASX: PNV) share price has been among the worst performers on the S&P/ASX 200 Index (ASX: XJO) on Wednesday following the release of its full year results for FY 2020. In afternoon trade the dermal regeneration solutio...

I think that every portfolio should have some exposure to the healthcare industry, including 1 or 2 small-caps that make up less than 5% of the total portfolio’s value. Emerging ASX biotech companies such as Opthea Ltd (ASX: OPT) and Polyn...

The Mesoblast Limited (ASX: MSB) share price could be set to surge after the Aussie biotech company had a huge regulatory breakthrough. What was the big breakthrough? Investors were holding out ahead of the US Oncologic Drugs Adviosry Comm...

Shares in the Aussie biotech company Mesoblast limited (ASX: MSB) continue to fall. In fact, the Mesoblast share price is down 37.0% since Monday’s close to $3.07 per share. It’s not unusual to see big valuation swings in the biotech space...

ASX biotech shares have been persistent outperformers in recent times. CSL Limited (ASX: CSL) is one of the largest ASX shares by market capitalisation with a $127.6 billion valuation based on the current CSL share price. However, CSL shar...

It’s hard to know where to invest $10,000 in ASX shares right now. I like to keep a long-term perspective to drown out the market noise. Here are a few of my favourite listed companies that I’d love to buy with some spare cash today. Where...

Now is a great time for beginners to start buying ASX shares. Yes, the market is volatile and the coronavirus pandemic has caused a lot of uncertainty. However, that also presents a buying opportunity. On top of that, the August earnings s...

Are you interested in adding some growth shares to your portfolio? Then I think the three named below could be great options. I feel all three are well-positioned to deliver above-average earnings growth over the next few years, which coul...

There are few ASX shares that I would buy today in this current climate. We are living in uncertain times with COVID-19 causing disruptions and impacting businesses across the globe. Yet despite this, valuations on some companies have soar...

Like all financial markets, ASX shares produce winners and losers. Some companies soar to spectacular market capitalisations as their product or service takes off. Others see share prices deteriorate as markets and demand shift. When inv...

It seems investors in these two ASX medical shares have taken the opportunity to lock in recent gains, sending prices down significantly in July. The Avita Therapeutics Inc (ASX: AVH) share price fell more than 30% in July as sales faltere...

I think the healthcare sector is a great place to invest with a long term view due to the favourable tailwinds that it is experiencing. These include ageing populations around the globe, increased chronic disease burden, and better technol...

As the economic outlook grows increasingly gloomy, many investors may be thinking of diversifying into defensive companies as a way of strengthening their portfolios. Generally, healthcare companies provide a good defence against a downtur...

Long-term shareholders of emerging ASX healthcare company Opthea Ltd (ASX: OPT) have endured a volatile 12 months. A little under a year ago, the Opthea share price was trading at a 52-week low of just $0.735. Then, in the space of a month...

The Polynovo Ltd (ASX: PNV) share price could be set to push higher in 2020. Here’s why I see some tailwinds behind the Aussie biotech ahead of its August earnings result. How has the Polynovo share price performed recently? The Polynovo s...

Like many companies, junior ASX healthcare company Medical Developments International Limited (ASX: MVP) has had a volatile 2020. After soaring to an all-time high of $11.78 in February, the Medical Developments share price was savaged in...

It’s been a great day for Australian shares today, with the S&P/ASX 200 Index (ASX: XJO) up by 2.3% at the time of  writing. In particular, the biotech sector and the tech sector have been standout performers. Here we examine 4 ASX bio...

Growth and dividends. That’s the holy grail that most ASX 200 share investors are looking for. It’s a rare combination, but one that can be an absolute gold mine if you can find it. If you’re looking to invest $10,000 for both growth and d...

The medical device industry includes any device which can diagnose, prevent, or treat a disease or other condition. Examples range from bandages and syringes to pacemakers and prostheses. These technologies save and improve lives by detect...

Shares in Melbourne-based medtech company Polynovo Ltd [ASX:PNV] have slid for a fifth consecutive day. Today’s dip in the PNV share price comes on the back of new funding for clinical trials of its proprietary NovoSorb regeneration solutio...

If you’re looking for growth shares to buy then I think the healthcare sector is a great place to start. This is because thanks to new technologies and favourable tailwinds, demand for healthcare services looks set to grow strongly over th...

A month away from hitting the ASX, 4DMedical has its sights set on the United States and its spiralling COVID-19 situation as a target market for its lung imaging technology. The Australian medtech is developing a patented X-ray imaging pla...

This year has been a bit of a mixed bag for ASX healthcare companies. Many have seen their share prices surge higher as investors sought out the safety of defensive shares in the face of extreme economic uncertainty. The share price of res...

Looking to add some growth shares to your portfolio next week? Listed below are three fast-growing companies that I think could be worth considering. Here’s why I think these ASX growth shares could be top long term investment options: Br...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.6% today to 5,919 points. The alarming COVID-19 spread continues in Melbourne with Victoria reporting 288 new cases today. However, two new infections in NSW that seemingly came from a Sydney...

The PolyNovo Ltd (ASX: PNV) share price is pushing higher in morning trade following the release of a trading update. At the time of writing the medical device company’s shares are up 2% to $2.49. What did PolyNovo announce? PolyNovo has b...